HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

4th Edition of

World Orthopedics Conference

September 24-26, 2026 | London, UK

Chondroblastoma

Chondroblastoma

Chondroblastoma is a rare and benign bone tumor that primarily affects the epiphyses (ends) of long bones, most commonly in the knee or proximal humerus. It predominantly occurs in individuals between the ages of 10 and 25. Chondroblastoma is characterized by the presence of chondroblasts, which are immature cartilage-forming cells. Symptoms may include localized pain, swelling, and reduced joint mobility. Radiographically, chondroblastoma typically appear as well-defined lesions with a characteristic soap-bubble or eccentric appearance on X-rays. Diagnosis is confirmed through imaging studies and often requires a biopsy for histological examination. Treatment options for chondroblastomas include curettage (surgical removal of the tumor) with or without bone grafting. While chondroblastomas are generally considered benign, they can be locally aggressive, and recurrence is possible. Regular follow-up and monitoring are crucial to detect any recurrence or complications. Comprehensive understanding of chondroblastomas is essential in orthopaedics, guiding appropriate diagnostic and therapeutic interventions for individuals affected by this relatively rare bone tumor.

 

Committee Members
Speaker at World Orthopedics Conference 2026 - Stephen S Tower

Stephen S Tower

University of Alaska Anchorage, United States
Speaker at World Orthopedics Conference 2026 - Ali Al Kaissi

Ali Al Kaissi

National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Ortho 2026 Speakers
Speaker at World Orthopedics Conference 2026 - Hussein Jaber

Hussein Jaber

University of Cambridge, United Kingdom
Speaker at World Orthopedics Conference 2026 - Jack Russek

Jack Russek

Touro University California, United States

Submit your abstract Today

Watsapp